These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 8289478

  • 1. Antisense BCR-ABL oligonucleotides induce apoptosis in the Philadelphia chromosome-positive cell line BV173.
    Smetsers TF, Skorski T, van de Locht LT, Wessels HM, Pennings AH, de Witte T, Calabretta B, Mensink EJ.
    Leukemia; 1994 Jan; 8(1):129-40. PubMed ID: 8289478
    [Abstract] [Full Text] [Related]

  • 2. Phosphorothioate BCR-ABL antisense oligonucleotides induce cell death, but fail to reduce cellular bcr-abl protein levels.
    Smetsers TF, van de Locht LT, Pennings AH, Wessels HM, de Witte TM, Mensink EJ.
    Leukemia; 1995 Jan; 9(1):118-30. PubMed ID: 7845006
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of chronic myelogenous leukemia cells harboring a BCR-ABL B3A2 junction by antisense oligonucleotides targeted at the B2A2 junction.
    Mahon FX, Ripoche J, Pigeonnier V, Jazwiec B, Pigneux A, Moreau JF, Reiffers J.
    Exp Hematol; 1995 Dec; 23(14):1606-11. PubMed ID: 8542954
    [Abstract] [Full Text] [Related]

  • 4. Antisense BCR-ABL oligomers cause non-specific inhibition of chronic myeloid leukemia cell lines.
    O'Brien SG, Kirkland MA, Melo JV, Rao MH, Davidson RJ, McDonald C, Goldman JM.
    Leukemia; 1994 Dec; 8(12):2156-62. PubMed ID: 7808004
    [Abstract] [Full Text] [Related]

  • 5. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
    Zhu XZ, Yu YZ, Fang YM, Liang Y, Lü QH, Xu RZ.
    Zhonghua Yi Xue Za Zhi; 2005 Jul 20; 85(27):1903-6. PubMed ID: 16255985
    [Abstract] [Full Text] [Related]

  • 6. Effects of BCR-ABL antisense oligonucleotides (AS-ODN) on human chronic myeloid leukemic cells: AS-ODN as effective purging agents.
    Wu AG, Joshi SS, Chan WC, Iversen PL, Jackson JD, Kessinger A, Pirruccello SJ, Sanger WG, Sharp JG, Verbik DJ.
    Leuk Lymphoma; 1995 Dec 20; 20(1-2):67-76. PubMed ID: 8750625
    [Abstract] [Full Text] [Related]

  • 7. The effect of bcr-abl antisense oligonucleotide on DNA synthesis and apoptosis in K562 chronic myeloid leukemia cells.
    Rowley PT, Keng PC, Kosciolek BA.
    Leuk Res; 1996 Jun 20; 20(6):473-80. PubMed ID: 8709619
    [Abstract] [Full Text] [Related]

  • 8. Morpholino Oligo Antisense efficiently suppresses BCR/ABL and cell proliferation in CML: specific inhibition of BCR-ABL gene expression by Morpholino Oligo Antisense in BCR-ABL(+) cells.
    Haririan M, Kaviani S, Soleimani M, Ghaemi SR, Delalat B, Atashi A.
    Hematology; 2012 Jan 20; 17(1):28-34. PubMed ID: 22549445
    [Abstract] [Full Text] [Related]

  • 9. An antisense Bcr-Abl phosphodiester-tailed methylphosphonate oligonucleotide reduces the growth of chronic myeloid leukaemia patient cells by a non-antisense mechanism.
    Smetsers TF, Linders EH, van de Locht LT, de Witte TM, Mensink EJ.
    Br J Haematol; 1997 Feb 20; 96(2):377-81. PubMed ID: 9029029
    [Abstract] [Full Text] [Related]

  • 10. Gene-targeted specific inhibition of chronic myeloid leukemia cell growth by BCR-ABL antisense oligodeoxynucleotides.
    Skórski T, Szczylik C, Malaguarnera L, Calabretta B.
    Folia Histochem Cytobiol; 1991 Feb 20; 29(3):85-9. PubMed ID: 1794439
    [Abstract] [Full Text] [Related]

  • 11. Elimination of clonogenic Philadelphia-positive cells using BCR-ABL antisense oligodeoxynucleotides.
    de Fabritiis P, Amadori S, Calabretta B, Mandelli F.
    Bone Marrow Transplant; 1993 Sep 20; 12(3):261-5. PubMed ID: 8241986
    [Abstract] [Full Text] [Related]

  • 12. Suppression of Philadelphia1 leukemia cell growth in mice by BCR-ABL antisense oligodeoxynucleotide.
    Skorski T, Nieborowska-Skorska M, Nicolaides NC, Szczylik C, Iversen P, Iozzo RV, Zon G, Calabretta B.
    Proc Natl Acad Sci U S A; 1994 May 10; 91(10):4504-8. PubMed ID: 8183938
    [Abstract] [Full Text] [Related]

  • 13. Treatment of Philadelphia leukemia in severe combined immunodeficient mice by combination of cyclophosphamide and bcr/abl antisense oligodeoxynucleotides.
    Skorski T, Nieborowska-Skorska M, Wlodarski P, Perrotti D, Hoser G, Kawiak J, Majewski M, Christensen L, Iozzo RV, Calabretta B.
    J Natl Cancer Inst; 1997 Jan 15; 89(2):124-33. PubMed ID: 8998181
    [Abstract] [Full Text] [Related]

  • 14. Circular antisense oligonucleotides inhibit growth of chronic myeloid leukemia cells.
    Rowley PT, Kosciolek BA, Kool ET.
    Mol Med; 1999 Oct 15; 5(10):693-700. PubMed ID: 10602778
    [Abstract] [Full Text] [Related]

  • 15. Antisense inhibition of P210 bcr-abl in chronic myeloid leukemia.
    Vaerman JL, Lewalle P, Martiat P.
    Stem Cells; 1993 Oct 15; 11 Suppl 3():89-95. PubMed ID: 8298481
    [Abstract] [Full Text] [Related]

  • 16. Effect of bcr-abl oligodeoxynucleotides on the clonogenic growth of chronic myelogenous leukaemia cells.
    de Fabritiis P, Skorski T, De Propris MS, Paggi MG, Nieborowska-Skorska M, Lisci A, Buffolino S, Campbell K, Geiser T, Calabretta B.
    Leukemia; 1997 Jun 15; 11(6):811-9. PubMed ID: 9177433
    [Abstract] [Full Text] [Related]

  • 17. Phosphorothioate-capped antisense oligonucleotides to Ras GAP inhibit cell proliferation and trigger apoptosis but fail to downregulate GAP gene expression.
    White JR, Gordon-Smith EC, Rutherford TR.
    Biochem Biophys Res Commun; 1996 Oct 03; 227(1):118-24. PubMed ID: 8858112
    [Abstract] [Full Text] [Related]

  • 18. IL-2 inhibits proliferation of K562 cells and reduces accumulation of bcr/abl mRNA and oncoprotein.
    Dilloo D, Hanenberg H, Lion T, Burdach S.
    Leukemia; 1995 Mar 03; 9(3):419-24. PubMed ID: 7885040
    [Abstract] [Full Text] [Related]

  • 19. A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukaemia cell lines.
    Algar EM, Khromykh T, Smith SI, Blackburn DM, Bryson GJ, Smith PJ.
    Oncogene; 1996 Mar 07; 12(5):1005-14. PubMed ID: 8649791
    [Abstract] [Full Text] [Related]

  • 20. Sequence specificity on the growth suppression and induction of apoptosis of chronic myeloid leukemia cells by BCR-ABL anti-sense oligodeoxynucleoside phosphorothioates.
    Maekawa T, Kimura S, Hirakawa K, Murakami A, Zon G, Abe T.
    Int J Cancer; 1995 Jul 04; 62(1):63-9. PubMed ID: 7601569
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.